FutureWorld (FWDG) 10-Q/A 4 Nov 14 2015 Q1 Quarterly report (amended) Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Jun. 30, 2014
Document And Entity Information [Abstract]	'
Entity Registrant Name	'FUTUREWORLD CORP.
Entity Central Index Key	'0001273988
Trading Symbol	'fwdg
Current Fiscal Year End Date	'--03-31
Entity Filer Category	'Smaller Reporting Company
Entity Common Stock, Shares Outstanding	451,373,966
Document Type	'10-Q/A
Document Period End Date	30-Jun-14
Amendment Flag	'false
Document Fiscal Year Focus	'2015
Document Fiscal Period Focus	'Q1

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Jun. 30, 2014	Mar. 31, 2014
Current assets	'	'
Cash	$133,437	$2,000
Accounts receivable	82	0
Inventory	11,485	0
Note receivable	39,888	0
Total current assets	184,892	2,000
Property & equipment, net of accumulated - net	'	'
Intangible property, net of accumulated - net	100,825	'
Deposits	2,327	0
Total Assets	288,044	2,000
Current liabilities	'	'
Accounts payable	937	6,350
Accrued expenses	1,137,341	1,089,530
Deferred revenue	'	0
Notes payable	132,016	0
Loans and notes payable, related parties	'	277,338
Total current liabilities	1,270,294	1,373,218
Notes payable to shareholder	223,844	0
Total liabilities	1,494,138	1,373,218
Stockholders' Equity	'	'
Preferred stock, 100,000,000 authorized, $.0001 par value: None issued and outstanding	'	'
Common stock, $.0001 par value, 4,900,000,000 shares authorized,and; 501,373,966 and 416,373,966 shares issued and outstanding, respectively	45,137	44,637
Additional paid-in capital	4,991,067	4,647,567
Minority interest in subsidiary	'	'
Accumulated deficit	-6,242,293	-6,063,422
Total stockholders' equity	-1,206,089	-1,371,218
Total Liabilities and Stockholders' Equity	$288,050	$2,000

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parentheticals) (USD $)	Jun. 30, 2014	Mar. 31, 2014
Statement of Financial Position [Abstract]	'	'
Preferred stock, shares authorized	100,000,000	100,000,000
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares issued	'	'
Preferred stock, shares outstanding	'	'
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	4,900,000,000	4,900,000,000
Common stock, shares issued	501,373,966	416,373,966
Common stock, shares outstanding	501,373,966	416,373,966

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (unaudited) (USD $)	3 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Income Statement [Abstract]	'	'
Revenues	$309	'
Direct costs	182	'
Gross Profit	127	'
Operating expenses:	'	'
Salaries and benefits	81,080	36,514
Consulting	'	'
Professional fees	57,800	3,977
General and administrative	14,933	'
Amortization and depreciation	19,883	11,054
Total operating expenses	173,570	51,545
Other income (expense):	'	'
Interest expenses	-5,301	-2,624
Sale of assets, net	'	'
Total other (expense)	-5,301	-2,624
Loss from operations before income taxes	-178,871	-54,169
Provision for income taxes	'	'
Loss from operations before minority interest	-178,871	-54,169
Minority Interest	'	'
Net loss	($178,871)	($54,169)
Earnings (loss) per share:	'	'
Basic (in dollars per share)	($0.00)	($0.00)
Weighted average shares outstanding	'	'
Basic (in shares)	501,373,966	446,373,966

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (unaudited) (USD $)	3 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Cash Flows from Operating Activities:	'	'
Net (loss) income	($178,871)	($54,169)
Adjustment to reconcile Net Income to net cash provided by operations:	'	'
Depreciation and amortization	19,883	11,054
Amortization of deferred revenue	'	'
Loss on sale of assets	'	'
Issuance of stock in settlement of services	'	'
Minority interest	'	'
Changes in assets and liabilities:	'	'
Accounts receivable	-82	'
Inventory	-11,485	'
Due from affiliate	'	'
Related party loans	'	-181,000
Prepaid and other	-2,332	'
Accounts payable	937	-5,330
Accrued expenses	47,944	-77,455
Customer deposits and deferred revenue	'	'
Net Cash (Used) Provided by Operating Activities	-124,006	-306,900
Cash Flows from Financing Activities:	'	'
Proceeds from issuance of stock	-100,825	'
Proceeds from issuance of note payable	79,464	'
Change in Investing Activity	'	'
Change in Financing Activity	344,000	'
Related party advances	-67,195	5,818
Net Cash (Used) Provided by Financing Activities	255,444	5,818
Net increase/decrease in Cash	131,438	-301,082
Cash at beginning of period	2,000	'
Cash at end of period	133,437	'
Supplemental cash flow information:	'	'
Interest paid	'	'
Taxes paid	'	'

History_of_the_Company_and_Nat

History of the Company and Nature of the Business	3 Months Ended
	Jun. 30, 2014
History Of The Company And Nature Of The Business [Abstract]	'
History of the Company and Nature of the Business	'
	1. History of the Company and Nature of the Business
	OUR HISTORY
	“We”, “us” and “our” refer to FutureWorld Corp., a Delaware corporation.
	The history of our incorporation and our ownership, in chronological order, is as follows:
	●	FUTUREWORLD CORP (the “Company”) was formed on June 22, 2002, as a Delaware corporation.
	●	On May 13, 2009, Mr. Talari converted the principal amount and accrued interest of one convertible note, and the accrued interest and a portion of the principal amount of a second note into 50,000,000 shares of our common stock respectively.  After these conversions, Mr. Talari legally and beneficially owned eighty-four percent of our common stock.
	●	June 10, 2009, FutureWorld Corp. acquires SeaTech Energy Inc., a Nevada corporation, for 150M shares in Common Stock or $1,500,000.
	●	On June 11, 2014, the Company changed its name to FutureWorld Corp.
	Nature of Business
	The address of our executive offices is: 3637 4th Street North, Saint Petersburg, FL 33704 and our telephone number at that address is 239-324-0000 or 727-474-1816. The address of our web site is www.futureworldcorp.com. The information at our web site is for general information and marketing purposes and is not part of this annual report for purposes of liability for disclosures under the federal securities laws.
	FutureWorld Corp., a Delaware corporation, is a U.S. diversified Industrial Hemp/ Medical Cannabis Company, which together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of Hemp/Cannabis products, services and technologies globally under the banner of Cannabis 2.0.
	FutureWorld Corp. is seeking to acquire minority or full interest in currently operating companies and disruptive technologies in the Industrial Hemp/Medical and Recreational Cannabis Industry globally; such as vaporizers, lab testing, tracking systems, security, CBD oil, testing kits, financial solutions, dispensaries and other needed components. Our goal is to provide our acquired companies, current and future shareholders a clear strategy for the growth of their companies and their investment in those companies.
	We currently provide multiple products that supply the burgeoning cannabis industry. The “picks and shovel” business model capitalizes of selling enterprises associated with the Industrial Hemp and Medical Cannabis industries products that are essential in their success. Our products solve long standing problems in cultivation, processing, and retail sales for industrial hemp and medical cannabis. The following divisions will continue to delve even further into purchasing existing products or developing brand new products as the wholesale and retail space continues to evolve. In addition, one primary focus is to manufacture, market, and sell products containing hemp derived CBD oil. We are invested in the following portfolio companies as subsidiaries;
	CB Scientific, Inc.:
	CB Scientific was organized in the state of Florida on 5/8/2014 with 40,000,000 shares of Common stock issued and outstanding in which all are held by FutureWorld Corp. CBD Oil- CBD is one of at least 60 cannabinoids found in hemp, and is non-psychoactive.
	The Cannabidiol “CBD” is a compound in cannabis that has significant medical effects, but does not make people feel “high” and can actually counter the psychoactive effects of THC. The reduced psychotropic of CBD-rich cannabis makes it an appealing treatment option for patients seeking anti-inflammatory, anti-pain, anti-anxiety, anti-psychotic, and/or anti-spasm effects without disconcerting lethargy. Scientific and clinical studies underscore CBD’s potential as a treatment for a wide range of conditions, including rheumatoid arthritis, diabetes, alcoholism, MS, chronic pain, schizophrenia, PTSD, antibiotic-resistant infections, epilepsy, and other neurological disorders. CBD has demonstrated neuro-protective and neurogenic effects, and its anti-cancer properties are currently being investigated at several academic research centers in the United States and elsewhere.
	The present usage for CBD oil in the United States is estimated to be approximately 1,000-2,000 Kilograms a year and growing and with a yearly value of around $200,000,000. Currently, the apparent current competitors are; CannaVest, Inc. and Medical Marijuana, Inc., which own portions of each other’s companies, are the primary supplier of CBD oil in the United States. They supply the product in bulk to affiliate distributors and sell it retail in plastic tubes that are refined up to three levels. Real Scientific Hemp Oil™ is their trademark name.
	CB Scientific is in the process of sourcing its own CBD oil from Europe. We are also developing plans to fund an overseas hemp cultivation project to provide a consistent and reliable supply to the United States and beyond. Currently, industrial hemp cultivation is legal in China, Australia, Austria, Canada, Chile, Denmark, Finland, France, Germany, Great Britain, Hungary, India, Italy, Japan, New Zealand, Poland, Russia, Spain Switzerland, and Turkey.
	CB Scientific will process the CBD oils that will be sold through our online presence for retailing industrial hemp oil-based Cannabidiol (CBD) nutritional supplements, wellness and personal care products and vapable CBD oils. DispenseTEK will market items such as CBD oil, CBD infused edibles & multiple hemp related items and cross market our vaporizers from URVape.com. DispenseTEK will be featuring scientific grade hemp oil which is highly sought after around the world. We will sell already recognizable brands including our own brands and drive internet sales through ads, videos, social media and Search Engine Optimization.
	The global Nutraceutical market is projected to be in excess of $200 billion by 2015 and the current US Nutraceutical and Dietary supplement market is valued at around $42 billion. URCBDOil.com will be at the forefront of this massive marketplace with significant opportunities. Cannabinoids (non-psychoactive CBD) have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of a wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and auto-immune diseases.
	Cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic events, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's, Parkinson's and HIV dementia. URCBDOil.com should be live by July 1, 2014. URCBDOil.com will assist FutureWorld to generate positive cash flow for both URVape and our CBD oil and CBD infused products..
	MedTest, Inc.:
	MedTest Inc. was organized in the state of Nevada on 4/28/2014 with 40,000,000 shares of Common stock issued and outstanding in which all are held by FutureWorld Corp. MedTest, Inc. a Nevada owned company based in Denver Colorado that FutureWorld recently purchased for cash, stock and a revenue sharing component. MedTest Inc. has a working relationship with Herbal Synergy LLC in Colorado and is developing new technologies specifically for cannabis analytics. Charles Steinberg’s credentials will prove to be an asset to MedTest Inc. Mr. Steinburg of Herbal Synergy has been one of the main men behind gas chromatography testing in Colorado. He has been a judge at five previous High Times Cannabis Cups. Mr. Steinberg will be a judge at the next three High Times Cannabis Cups (San Francisco, CA: June 28th – 29th, Clio, MI July 26th – 27th, Seattle WA Sept 6th – 7th). Herbal Synergy LLC has pioneered residual solvent testing for medical cannabis and has always strived to help patients know exactly what they are buying. MedTest Inc. believes every product sold to patients as “Medical Quality” should be inspected for health benefits, safety, consistency, purity, potency and packaged properly for distribution.
	URVape, Inc.:
	URVape was organized in the state of Florida on 6/2/2014 with 40,000,000 shares of Common stock issued and outstanding in which all are held by FutureWorld Corp. URVape™ is our brand name vaporizer pen which is sold with a charger and refill bottles. We market the product at URVape.com. It is our own trademarked vaporizer being marketed and sold online and in retail shops. The product is cutting edge design and requires puffing on the pen to facilitate battery use. The URVape vaporizing pen is sleek and lightweight. URVape will initially have oil vaporizers available and dry herb versions available in the coming months.
	URVape 1.0 - For use with oil extracts
	Powered by battery, vaporizers extract the active ingredients from cannabis by heating it to a temperature lower than required for combustion. When air is drawn through the heated cannabis it emits a vapor that is inhaled. URVape is;
	URVape - Extremely easy to use. No Buttons. Just draw through the mouthpiece and the unit automatically heats up to release oil vapor.
	LED lights on the bottom light up when you inhale, Auto shut off after 8 seconds, Discreet, Stylish and Sleek, Stylus on end of pen, Long Battery Life - Lasts for 4-5 days depending on number of puffs, FutureWorld has identified three key long-term items sweeping the globe that solidify URVape’s entry into the market:
	The decriminalization and legalization of cannabis for medicinal and recreational use - The adoption of electronic vaporizing by the world’s 1.2 Billion smokers - eCig or vaporizer market is the fastest market within the tobacco (free) industry and estimated to be a multi-billion dollar industry within few years.
	HempTech Corp:
	HempTech Corp. was organized in the state of Delaware on 3/19/2014 with 40,000,000 shares of Common stock issued and outstanding in which all are held by FutureWorld Corp. HempTech Corp has several products available specifically geared to helping cultivators of industrial hemp and medical cannabis maximum yields while helping to control costs. CaNNaLyTiX™ , SPIDer™, SmartSense™ ,Smart.NRG™ , and CaNNaTRAK™.
	CaNNaLyTiX™ “A picture is word a thousand words” and being able to visualize all the various aspects of a cultivation enterprise solves challenges before they become problems. CaNNaLyTiX™ is a dashboard controller system that allows the various computer systems to be integrated throughout a cultivator’s infrastructures. Using state-of –the-art API connecting software packages, CaNNaLyTiX™ can allow all computer systems to be monitored with the ease of a smartphone app and the robust hardware of integrated servers or cloud-based application.
	CaNNaTRAK™- the next generation of barcode & RFID tracking systems for keeping pace with the extensive demands of seed to sale tracking of Hemp/Cannabis for state compliance. We are currently developing “game changer” modifications that will make it the ultimate software system in the industry. CannaTRAK’s Asset Tracking Management Software automates the major aspects of the Asset Life Cycle. The Product suite is made up of modules, which are able to operate independently of one another, are able to be configured to work together, or to be integrated with non-native applications. CaNNaTRAK™’s software easily tracks assets using bar coding, radio frequency (RFID), imaging, and wireless technologies. CaNNaTRAK™ software is designed under the client/server architecture, is multi-user and menu-driven following industry-standard MS Windows protocols and graphical user interfaces. CaNNaTRAK™ applications are compatible with MS Windows XP, Vista, Windows 7 & 8.1 operating systems and with SQL Server 2008 through 2013.
	CaNNaTRAK’s mobile information applications are compatible with Windows Mobile devices and are tightly integrated with; bar coding, RFID, GPS, imaging, biometrics and wireless technologies. Due to the State law, legal governance, compliance and tax reasons, we believe CaNNaTRAK™ will be an invaluable tool for legal compliance and profitability from growers to dispensers of the legal medicinal marijuana. Over the past decade, 22 states have approved the use of medicinal marijuana. Medicinal marijuana has become an alternative to traditional treatments for patients with clinical diseases such as cancer and HIV/AIDS. The medicinal marijuana market is estimated to be valued in the billions of dollars initially and may provide hundreds of millions of dollars tax revenue for the state’s tax coffers.
	We believe compliance and governance will be a big concern for the state offices overseeing the cannabis lifecycle and CaNNaTRAK™ will be an invaluable tool to comply and monitor for the medicinal marijuana industry. Our competition presently consists of the MITS system being used in the state of Colorado, the BioTrackTHC system being used in the state of Washington, and MJ Freeway. Our primary plan is to be ready for the state of Florida when medical marijuana passes on Nov. 4th, 2014. Certainly we will look to enter every burgeoning market including Florida. Florida is set to be the 2nd largest Cannabis market in the United States behind California
	SPIDer (Secure Perimeter Intrusion Detection Network) is a system to meet the needs of theft and malicious attacks. While the economy is seeing improvement, theft, site destruction, and malicious activity are still happening at an alarming rate and within the legal Cannabis/Hemp industry surging forward we can expect no change particularly because of its specific draw. The SPIDer systems consist of 3 levels of detection to identify intruders and threats in areas that are restricted.
	The first level utilizes an electronically charged coaxial cable woven into your chain link fencing. Excessive fence movement will set off an alarm through your network notification system that someone is attempting to enter your facility. This is a very cost effective means to secure your site to meet security requirements for your company. The second level consists of a visual intrusion monitoring system. It is a wireless, battery operated, and connected through the cellular network. It provides 24/7 monitoring and notification through the internet and email system. Once an intruder is identified an alarm is sent to the security team with a picture that allows you to identify if this is an authorized or unauthorized person. If it is an unauthorized person you can take the appropriate action.
	The network system can quickly be deployed and moved to provide security coverage as needed. The third level is a multi-level detection and verification system that uses both level one and level two to rapidly identify a potential intruder and provide you information for a rapid decision. The combination of the two systems provides the additional barriers for quick action. Sometimes seconds are critical in preventing serious damage or theft at your site. The command center software provides intrusion notification to your network center and to individuals via email. For level two and three you receive a picture that enables you to make a more informed and quicker decision concerning your action.
	The SPIDer solution addresses the potential threat facing the entire Cannabis/Hemp industry. With this system you are able to arm your security team with information that enables them to be proactive in addressing these costly activities. Compliance with state rules and regulations for the Cannabis/ Hemp industry is going to be essential. Though there are many security companies on the market, few are adapting themselves to the Cannabis industry.
	SmartSense- offers wireless security and smart sensor mesh network for precision agriculture, irrigation systems, and greenhouses for the hemp industry. Our Smart Agriculture models allow monitoring multiple environmental parameters involving a wide range of applications with smart sensors such as Leaf Wetness, Atmospheric Pressure, Solar Radiation, Air Temperature / Humidity, Soil Temperature / Moisture, Ultraviolet Radiation and etc. The smart sensor information will be collected and sent via the cloud to the central office for analysis and procedural modifications. FutureWorld is not aware of another competitor in the United States. FutureWorld, through, HempTech plans on marketing the product to large and medium sized grow facilities as they will have the greatest need.
	Smart.NRG- offers tools to analyze every aspect of a cultivator’s energy usage. Being fully integrated with CaNNaLyTiX™, one can visualize energy consumption in real-time and track historical usage. The software’s predictive functionality also helps optimize energy use challenges proactively. We believe a cultivator’s huge electric bills can be scaled back when the entire grow is looked at as a complete and fully integrated operation.
	SmartGROW- HempTech is developing their own proprietary organic soils and nutrients that will be specifically marketed and made to bolster the Hemp/Cannabis community for industrial hemp farms, to Cannabis grows of various sizes, and to home-based potted plant grows for personal use. As such, every cultivator of marijuana needs the right kind of fertilizer and pesticides/herbicides to proper grow and achieve quality products. But what is great about getting into soil is that hemp/cannabis is only one part of a huge agricultural market. The company will sell its products to the entire farming community which is a great revenue source, but the additional focus to the cannabis market will set us apart. The competition in the market for this focused marketing is extensive yet we feel there is substantial room in the space for growth..
	We will manufacture a complete line of innovative sustainable and organic fertilizers, pesticides, fungicides, and soil amendments. The products we will use are currently used all over the world, in all sorts of growing environments like organic and conventional farms, golf courses, nurseries, lawns, gardens, and greenhouses, but we will be adding specific mixtures targeted to just the Cannabis/Hemp community. We have access to a modern laboratory and manufacturing facility and will be able to develop special formulations for whatever unique growing situation someone may have. In that way, the consumer can save money and pay only for the nutrients their plant needs. We intend on opening up a new company for this purpose and joint venturing with an agricultural industry expert. Negotiations for the new company are currently underway. FutureWorld will own the intellectual rites in conjunction with the JV.
	CaNNaBoX™- Much like a bank ATM, the CaNNaBoX™ machine operates with the swipe of a card, which will verify identity, age and prescription information of a medical marijuana patient before releasing measured packages of marijuana. The upside is you won't have to be waited on by an assistant if you don't require consultation and the location is busy. The machine is capable of holding several hundred items in multiple forms of marijuana. CaNNaBoX™ is a secure robotic device specifically designed for dispensing cannabis products in secure prepackaged amounts, in complete accordance with state law requirements, in licensed dispensaries, and only to legal buyers .
	FutureWorld has teamed up with American Green to brand the Zazzz Dispensary machine with the CaNNaBoX™ logo and distribute the product across the United States and beyond. Presently, we are aware of the Zazzz machine presented by American Green, which is first to the market, MedBox Inc.’s machine, and a vending machine product by Endexx Corp. The model for FutureWorld is to bring 1500 units to market within a couple years in accordance with our JV goals alongside American Green and its Zazzz machine.
	There will be a revenue sharing agreement with American Green and FutureWorld for every placed CaNNaBoX™ machine via monthly leasing and transaction costs. We are currently putting together the details of the JV with American Green and beginning the marketing and design phase of our product. Revenues are purely a function of quantity at this point. A monthly leasing fee of approximately $150 dollars a month and a transaction cost somewhere between $1.50 and $2.00 per. Competing brands are to look for a large upfront expenditures from dispensaries for the machines which we believe will make their sales model harder to actual achieve sales nationwide.
	CaNNaBoX™ will be marketed exclusively through our new dispensary division, DispenseTek. DispenseTek was created to market and sell dispensary related products and services including but not limited to CaNNaBoX™. It is important to understand, CaNNaBoX™ robotic dispensaries are secure delivery and control systems for use in licensed cannabis dispensaries and not “vending machines”. Their specific design benefits public safety, governance, dispensaries, and consumers.
	CannaPKG, Inc. - FutureWorld is currently in the process of finalizing its purchase of CannaPKG, Inc. CannaPKG is marketed on CannaPKG.com. Many of the products in the industry from edibles, to oil cartridges, vaporizers to plant buds all need special packaging of which FutureWorld intends to play an integral part. Smell proof bags, and jars along with an assortment of a great many other industry products will be available. Our biggest competitor would be considered to be Cannaline.com. The site will utilize Search Engine Optimization and social media. In addition, we will employ sales agents to visit retailers who may look to supply their stores with our products.
	CaNNaBit™- CaNNaBit™ offers Bitcoin and Fiat currency exchange services; payment processing; on-line real-time currency trading; cash management, namely, facilitating transfers of electronic cash equivalents; digital currency exchange transaction services for transferrable electronic cash equivalent for dispensaries nationwide. Banking has been a big issue for the Cannabis dispensaries due to the current federal ban and classification of Cannabis. Hence most banking groups would not risk fines and closure by the federal government providing banking services for the growers and dispensaries in the Cannabis industry.

Basis_of_Presentation_Business

Basis of Presentation, Business and Summary of Significant Accounting Policies	3 Months Ended
	Jun. 30, 2014
Business Description And Basis Of Presentation [Abstract]	'
Basis of Presentation, Business and Summary of Significant Accounting Policies	'
	2.   Basis of Presentation, Business and Summary of Significant Accounting Policies
	Basis of Presentation
	In the opinion of management, all adjustments consisting of normal recurring adjustments necessary for a fair statement of (a) the result of operations for the six month periods ended June 30, 2014 and 2013; (b) the financial position at June 30, 2013; and (c) cash flows for the three month periods ended June 30, 2014 and 2013, have been made. Management believes that these estimates are reasonable and have been discussed with the Board of Directors; however, actual results could differ from those estimates
	The accompanying unaudited financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. For further information regarding the Company's significant accounting policies, refer to the audited consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2013 filed with the Securities and Exchange Commission on March 20, 2014.
	Our financial statements may not be comparable to companies that comply with public company effective dates. Due to our election not to opt out of the extended transition period that allows us to delay the adoption of new or revised accounting standards that have different effective dates for public and private companies until those standards apply to private companies. All Amounts referenced in these Financial Statements and this Report are in US Dollars unless otherwise stated.
	Nature of the Business, and History of the Company and its Subsidiaries
	The nature of the business and the history of the Company and its subsidiaries are as follows:
	Nature of the Business
	FutureWorld Corp., a Delaware corporation, is a U.S. diversified Hemp/Cannabis Company, listed on the Over the Counter exchange, which was originally formed to capitalize on the burgeoning markets in renewable and alternative energy technologies, but has since changed direction and moved into the Hemp/Cannabis space. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of Hemp/Cannabis products, services and technologies globally.
	FutureWorld is seeking to acquire minority or full interest in currently operating companies and disruptive technologies in the Industrial Hemp/Medical and Recreational Cannabis Industry globally; such as vaporizers, lab testing, tracking systems, security, CBD oil, testing kits, financial solutions, dispensaries and other needed components. Our goal is to provide our acquired companies, current and future shareholders a clear strategy for the growth of their companies and their investment in those companies.
	Summary of Significant Accounting Policies
	Principles of Consolidation
	The consolidated financial statements include the accounts and operations of FutureWorld Corp., and its wholly owned subsidiaries, URVape, Inc., HempTech Corp., CB Scientific and MedTest, Inc. All intercompany transactions have been eliminated in the consolidated financial.
	Basis of Accounting
	The Company maintains its financial records and financial statements on the accrual basis of accounting, in conformity with generally accepted accounting principles in the United States of America. The accrual basis of accounting provides for matching of revenues and expenses in the period they were earned and incurred.
	Cash and Cash Equivalents
	For purposes of reporting cash flows, the Company considers all cash accounts that are not subject to withdrawal restrictions or designated for assets acquisitions, and certificates of deposit that have an original maturity of three months or less when purchased, to be cash equivalents. The Company believes it is not exposed to any significant credit risk on cash and cash equivalents.
	Fair Value of Financial Instruments
	The following methods and assumptions were used by the Company in estimating its fair value disclosures for financial instruments:
		•	Cash and Cash Equivalents, Accounts Receivable, Prepaid Expenses, Accounts Payable,  and  Accrued Expenses :
			The carrying amount reported in the balance sheets for these items approximates fair value because of the short maturity of these instruments.
		•	Loans and Notes Payable to Related Parties:
			The carrying value of loans and notes payable to related parties approximates fair value as each of the notes payable carries an interest rate commensurate with commercial borrowing rates available to the Company.
			As of June 30, 2014 and 2013, the fair values of the Company’s financial instruments approximate their historical carrying amount.
	Property and Equipment
	Property and equipment are recorded at historical cost.  Depreciation is computed on the straight-line method over estimated useful lives of the respective assets, ranging from three to seven years.  The carrying amount of all long-lived assets is evaluated periodically to determine if adjustment to the depreciation periods or the unamortized balance is warranted.  Based upon the Company's most recent analysis, management believes that no impairment of property and equipment exists at June 30, and March 31, 2014.
	Capitalized Software Development Costs
	The Company capitalizes software development costs, under which certain software development costs incurred subsequent to the establishment of technological feasibility have been capitalized and are being amortized over the estimated lives of the related products. Capitalization of computer software costs is discontinued when the computer software product is available to be sold, leased, or otherwise marketed.
	Amortization begins when the product is available for release and sold to customers. Software development costs will be amortized based on the estimated economic life of the product, anticipated to be 10 years.
	Impairment of Long-Lived Assets
	Periodically, the Company assesses the recoverability of the Company’s intangible assets, consisting of the Intellectual Property & licensing for CaNNaTRAK, SmartSense, CaNNaLyTiX and its trademark, and record an impairment loss to the extent that the carrying amounts of the assets exceed its fair value.  Based upon management's most recent analysis, the Company believes that no impairment of the Company’s tangible or intangible assets exist at June 30, and March 31, 2014.
	Revenue Recognition
	The Company is principally in the business of providing solutions to the cannabis industry that incorporates our CaNNaTRAK, SmartSense, and CaNNaLyTiX technologies. Contracts include multiple revenue components, comprised of our software licensing, hardware platforms, installation, training and maintenance.  In accordance with ASC 605-25 Multiple-Element Arrangements, revenue from licensing the software will be recognized upon installation and acceptance of the software by customers.  When a software sales arrangement includes rights to customer support, the portion of the license fee allocated to such support is recognized ratably over the term of the arrangement, normally one year.  Revenue from professional services arrangements will be recognized in the month in which services are rendered over the term of the arrangement.
	Revenue associated with software sales to distributors is recognized, net of discounts, when the Company has performed substantially all its obligations under the arrangement.  Until such time as substantially all obligations under the arrangement are met, software sales are recognized as deferred revenue.  Costs and expenses associated with deferred revenue are also deferred.  When a software sales arrangements include a commitment to provide training and/or other services or materials, the Company estimates and records the expected costs of these training and/or other services and/or materials.
	Our revenue recognition policy is in accordance with generally accepted accounting principles, which requires the recognition of sales when there is evidence of a sales agreement, the delivery of goods has occurred, the sales price is fixed or determinable and the collectability of revenue is reasonably assured.
	Intangible assets – Goodwill
	The Company's goodwill associated with its acquisitions is not amortized. Management reviews goodwill for impairment at least on an annual basis and at other times when existing conditions raise substantial questions about their recoverability. An impairment charge is recognized in the period which management determines that the assets are impaired. Recoverability is assessed based on the carrying amount of the asset and its fair value which is generally determined based on the sum of the undiscounted cash flows expected to result from the use and the eventual disposal of the asset, as well as specific appraisal in certain instances. An impairment loss is recognized when the carrying amount is not recoverable and exceeds fair value.
	Foreign currency translation
	The Company’s functional currency and its reporting currency is the United States Dollar.
	Cost of Goods Sold
	The Company recognizes the direct cost of purchasing product for sale, including freight-in and packaging, as cost of goods sold in the accompanying income statement.
	Cash and cash equivalents
	The Company includes in cash and cash equivalents all short-term, highly liquid investments that mature within three months of their acquisition date. Cash equivalents consist principally of investments in interest-bearing demand deposit accounts and liquidity funds with financial institutions and are stated at cost, which approximates fair value. For cash management purposes the company concentrates its cash holdings in an account at Bank of America.
	Inventory
	Inventory consists of finished product, URVape electronic vaporizing cigarettes valued at the lower of cost or market valuation under the first-in, first-out method of costing.
	Stock Based Compensation
	The Companies estimates the fair value of share-based payment awards to employees and directors on the date of grant using an option-pricing model. For stock-based awards issued to employees and directors, stock-based compensation is attributed to expense using the straight-line single option method, which is consistent with how the prior-period pro-forma were provided. Stock-based compensation expense recognized in the Statements of Operations for the years ended March 31, 2013 and 2012 included compensation expense for share-based payment awards granted prior to, but not yet vested based on the grant date fair value estimated and compensation expense for the share-based payment awards granted subsequent to January 1, 2006 based on the grant date fair value estimated.
	The Company’s determination of fair value of share-based payment awards to employees and directors on the date of grant using the Black-Scholes model, which is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to our expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors.
	Income Taxes
	The Company records federal and state income tax liability at the federal and state rates after allowances. Deferred income taxes are provided on the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.
	Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
	Tax benefit from an uncertain tax position may be recognized in the financial statements when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. Income tax positions must meet a more-likely-than-not recognition threshold at the effective date to be recognized and in subsequent periods.
	The Company adopted a policy under which, if required to be recognized in the future, they will classify interest related to the underpayment of income taxes as a component of interest expense and will classify any related penalties in selling, engineering, general and administrating expenses in the statement of operations.
	Advertising Costs
	Advertising costs are charged to operations as incurred.
	Earnings (Loss) Per Share
	Basic EPS is calculated by dividing earnings (loss) available to common shareholders by the weighted average number of common shares outstanding during each period.  Diluted EPS is similarly calculated, except that the denominator includes common shares that may be issued subject to existing rights with dilutive potential, except when their inclusion would be anti-dilutive.
	Based on an estimated current value of the Company’s stock being equal to or less than the exercise price of the warrants, none of the shares assumed issued upon conversion of the warrants, nor any of the stock assumed issued under the Company's Incentive Stock Plan are included in the computation of fully diluted loss per share, since their inclusion would be anti-dilutive.
	Impact of Recently Issued Accounting Pronouncements
	We have reviewed accounting pronouncements and interpretations thereof that have effectiveness dates during the periods reported and in future periods. We believe that the following impending standards may have an impact on our future filings. The applicability of any standard is subject to the formal review of our financial management and certain standards are under consideration.
	Other recent accounting pronouncements issued by the FASB, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future financial statements.

Going_Concern

Going Concern	3 Months Ended
	Jun. 30, 2014
Liquidity Disclosure [Abstract]	'
Going Concern	'
	3.  Going Concern
	For the year ended June 30, 2014, the Company incurred a net loss of $178,871 and a cumulative net loss since inception of $6,242,293.  As of June 30, 2014, the Company had a working capital of $133,437 and $133,437 in cash with which to satisfy any future cash requirements.  These conditions raise substantial doubt about the Company's ability to continue as a going concern.  The Company depends upon capital derived from future financing activities such as loans from its officers and directors, subsequent offerings of its common stock or debt financing in order to operate and grow the business either directly or through its subsidiary.  There can be no assurance that the Company will be successful in raising such capital.  The key factors that are not in the Company's control and that may have a direct bearing on operating results.  These factors include, but are not limited to, acceptance of the Company’s business plan, the ability to raise capital in the future, the ability to expand its customer base, and the ability to hire key employees to grow the business.  There may be other risks and circumstances that management may be unable to predict.

Property_and_Equipment

Property and Equipment	3 Months Ended
	Jun. 30, 2014
Property, Plant and Equipment [Abstract]	'
Property and Equipment	'
	4.  Property and Equipment
	Property and equipment as of June 30, 2014 and June 30, 2013 consists of the following:
		2014		2013
	Computer equipment	$	-	$	9,873
	Furniture and fixtures		-		17,070
			-		26,943
	Accumulated depreciation		-		24,369
	Net	$	-	$	2,574

Stock_Issuances

Stock Issuances	3 Months Ended
	Jun. 30, 2014
Stock Issuances [Abstract]	'
Stock Issuances	'
	5.   Stock Issuances
	We issued 5,000,000 shares of our restricted Common stock for the purchase of MedTest, Inc.

Related_Parties_Transactions

Related Parties Transactions	3 Months Ended
	Jun. 30, 2014
Related Parties Transactions [Abstract]	'
Related Parties Transactions	'
	6.     Related Parties Transactions
	None.

Accrued_Expenses

Accrued Expenses	3 Months Ended
	Jun. 30, 2014
Accrued Liabilities, Current [Abstract]	'
Accrued Expenses	'
	7.  Accrued Expenses
	Accrued expenses at June 30 and March 31, 2014 were as follows:
		2014		2013
	Accrued salaries	$	1,072,714	$	831,527
	Payroll tax liabilities				41,576
	Accrued interest		64,935		0
	Accrued penalties				-
		$	1,137,649	$	873,103

Related_Parties_Disclosures

Related Parties Disclosures	3 Months Ended
	Jun. 30, 2014
Related Party Transactions [Abstract]	'
Related Parties Disclosures	'
	8.   Related Parties Disclosures
	Loan from Saeed (Sam) Talari
	Mr. Talari has advanced funds to the Company at various times. On April 1, 2010 the Company issued a promissory note with an initial balance of $306,319 bearing interest at 5%. This note allows Mr. Talari to advance additional funds to the Company as needed. At June 30, 2014 and 2013, the balance due to Mr. Talari on this Promissory Note is $223,844 and $299,118 respectively, and the accrued interest thereon at June 30 and March 31, 2014 is $64,935 and $45,048 respectively.

Employment_Agreements

Employment Agreements	3 Months Ended
	Jun. 30, 2014
Employment Agreements [Abstract]	'
Employment Agreements	'
	9. Employment Agreements
	Sam Talari
	On January 1, 2012, the Company entered into a three-year Employment Agreement with Mr. Talari, the Company’s Acting Chief Executive Officer, and one of the Company's directors. The Agreement is automatically extended for additional one-year periods without further action from the Company or the executive, unless notice of termination is given by either party within 90 days of the end of any periods. The Agreement provides for (a) a base salary of $9,371 per month, with a 5% increase per annum and (b) all group insurance plans and other benefit plans and programs made available to the Company’s management employees. The balance of accrued salaries payable to Mr. Talari is $1,037,284 and $900,733 as of J June 30 and March 31, 2014 respectively.
	Cameron Cox
	On April 15, 2014, the Company entered into a three-year Employment Agreement with Mr. Cox, the Company’s Acting Vice President of Business Development. The Agreement is automatically extended for additional one-year periods without further action from the Company or the executive, unless notice of termination is given by either party within 90 days of the end of any periods. The Agreement provides for (a) a base salary of $3,000 per month, with a 5% increase per annum, and (b) all group insurance plans and other benefit plans and programs made available to the Company’s management employees.
	Bill Short
	On April 24, 2014, the Company entered into a three-year Employment Agreement with Mr. Short, the Company’s Acting Chief Operations Officer. The Agreement is automatically extended for additional one-year periods without further action from the Company or the executive, unless notice of termination is given by either party within 90 days of the end of any periods. The Agreement provides for (a) a base salary of $3,000 per month, with a 5% increase per annum, and (b) all group insurance plans and other benefit plans and programs made available to the Company’s management employees.
	Kevin Defant
	On April 21 , 2014, the Company entered into a three-year Employment Agreement with Mr. Defant, the Company’s Acting Tech Director. The Agreement is automatically extended for additional one-year periods without further action from the Company or the executive, unless notice of termination is given by either party within 90 days of the end of any periods. The Agreement provides for (a) a base salary of $2,000 per month, with a 5% increase per annum, and (b) all group insurance plans and other benefit plans and programs made available to the Company’s management employees.
	Derek Lebahn
	On May 15, 2014, the Company entered into a three-year Employment Agreement with Mr. Lebahn, the Company’s Acting President of the CB Scientific Division. The Agreement is automatically extended for additional one-year periods without further action from the Company or the executive, unless notice of termination is given by either party within 90 days of the end of any periods. The Agreement provides for (a) a base salary of $2,000 per month, with a 5% increase per annum, and (b) all group insurance plans and other benefit plans and programs made available to the Company’s management employees.
	Charles Steinberg
	On May 15, 2014, the Company entered into a three-year Employment Agreement with Mr. Steinberg, the Company’s Acting Vice President of the CB Scientific Division. The Agreement is automatically extended for additional one-year periods without further action from the Company or the executive, unless notice of termination is given by either party within 90 days of the end of any periods. The Agreement provides for (a) a base salary of $2,000 per month, with a 5% increase per annum, and (b) all group insurance plans and other benefit plans and programs made available to the Company’s management employees.
	Joseph Kelly
	On June 18, 2014, the Company entered into a three-year Employment Agreement with Mr. Kelly, the Company’s Acting Product Development Executive for the CB Scientific Division. The Agreement is automatically extended for additional one-year periods without further action from the Company or the executive, unless notice of termination is given by either party within 90 days of the end of any periods. The Agreement provides for (a) a base salary of $850 per month, with a 5% increase per annum, and (b) all group insurance plans and other benefit plans and programs made available to the Company’s management employees.
	Scott Zabrek
	On June 18, 2014, the Company entered into a three-year Employment Agreement with Mr. Zabrek, the Company’s Acting President of CannaPKG, Inc Division. The Agreement is automatically extended for additional one-year periods without further action from the Company or the executive, unless notice of termination is given by either party within 90 days of the end of any periods. The Agreement provides for (a) a base salary of $2,000 per month, with a 5% increase per annum, and (b) all group insurance plans and other benefit plans and programs made available to the Company’s management employees.

Commitments_and_contingencies

Commitments and contingencies	3 Months Ended
	Jun. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and contingencies	'
	10. Commitments and contingencies
	During the Company's initial stage, it has limited need for use of office space or equipment.  The Company operates out of office space provided by the principals at no cost to the Company in Saint Petersburg, Florida.

Basis_of_Presentation_Business1

Basis of Presentation, Business and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Jun. 30, 2014
Accounting Policies [Abstract]	'
Principles of Consolidation	'
	Principles of Consolidation
	The consolidated financial statements include the accounts and operations of FutureWorld Corp., and its wholly owned subsidiaries, URVape, Inc., HempTech Corp., CB Scientific and MedTest, Inc. All intercompany transactions have been eliminated in the consolidated financial.
Basis of Accounting	'
	Basis of Accounting
	The Company maintains its financial records and financial statements on the accrual basis of accounting, in conformity with generally accepted accounting principles in the United States of America. The accrual basis of accounting provides for matching of revenues and expenses in the period they were earned and incurred.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	For purposes of reporting cash flows, the Company considers all cash accounts that are not subject to withdrawal restrictions or designated for assets acquisitions, and certificates of deposit that have an original maturity of three months or less when purchased, to be cash equivalents. The Company believes it is not exposed to any significant credit risk on cash and cash equivalents.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	The following methods and assumptions were used by the Company in estimating its fair value disclosures for financial instruments:
		•	Cash and Cash Equivalents, Accounts Receivable, Prepaid Expenses, Accounts Payable,  and  Accrued Expenses :
			The carrying amount reported in the balance sheets for these items approximates fair value because of the short maturity of these instruments.
		•	Loans and Notes Payable to Related Parties:
			The carrying value of loans and notes payable to related parties approximates fair value as each of the notes payable carries an interest rate commensurate with commercial borrowing rates available to the Company.
			As of June 30, 2014 and 2013, the fair values of the Company’s financial instruments approximate their historical carrying amount.
Property and Equipment	'
	Property and Equipment
	Property and equipment are recorded at historical cost.  Depreciation is computed on the straight-line method over estimated useful lives of the respective assets, ranging from three to seven years.  The carrying amount of all long-lived assets is evaluated periodically to determine if adjustment to the depreciation periods or the unamortized balance is warranted.  Based upon the Company's most recent analysis, management believes that no impairment of property and equipment exists at June 30, and March 31, 2014.
Capitalized Software Development Costs	'
	Capitalized Software Development Costs
	The Company capitalizes software development costs, under which certain software development costs incurred subsequent to the establishment of technological feasibility have been capitalized and are being amortized over the estimated lives of the related products. Capitalization of computer software costs is discontinued when the computer software product is available to be sold, leased, or otherwise marketed.
	Amortization begins when the product is available for release and sold to customers. Software development costs will be amortized based on the estimated economic life of the product, anticipated to be 10 years.
Impairment of Long-Lived Assets	'
	Impairment of Long-Lived Assets
	Periodically, the Company assesses the recoverability of the Company’s intangible assets, consisting of the Intellectual Property & licensing for CaNNaTRAK, SmartSense, CaNNaLyTiX and its trademark, and record an impairment loss to the extent that the carrying amounts of the assets exceed its fair value.  Based upon management's most recent analysis, the Company believes that no impairment of the Company’s tangible or intangible assets exist at June 30, and March 31, 2014.
Revenue Recognition	'
	Revenue Recognition
	The Company is principally in the business of providing solutions to the cannabis industry that incorporates our CaNNaTRAK, SmartSense, and CaNNaLyTiX technologies. Contracts include multiple revenue components, comprised of our software licensing, hardware platforms, installation, training and maintenance.  In accordance with ASC 605-25 Multiple-Element Arrangements, revenue from licensing the software will be recognized upon installation and acceptance of the software by customers.  When a software sales arrangement includes rights to customer support, the portion of the license fee allocated to such support is recognized ratably over the term of the arrangement, normally one year.  Revenue from professional services arrangements will be recognized in the month in which services are rendered over the term of the arrangement.
	Revenue associated with software sales to distributors is recognized, net of discounts, when the Company has performed substantially all its obligations under the arrangement.  Until such time as substantially all obligations under the arrangement are met, software sales are recognized as deferred revenue.  Costs and expenses associated with deferred revenue are also deferred.  When a software sales arrangements include a commitment to provide training and/or other services or materials, the Company estimates and records the expected costs of these training and/or other services and/or materials.
	Our revenue recognition policy is in accordance with generally accepted accounting principles, which requires the recognition of sales when there is evidence of a sales agreement, the delivery of goods has occurred, the sales price is fixed or determinable and the collectability of revenue is reasonably assured.
Intangible assets - Goodwill	'
	Intangible assets – Goodwill
	The Company's goodwill associated with its acquisitions is not amortized. Management reviews goodwill for impairment at least on an annual basis and at other times when existing conditions raise substantial questions about their recoverability. An impairment charge is recognized in the period which management determines that the assets are impaired. Recoverability is assessed based on the carrying amount of the asset and its fair value which is generally determined based on the sum of the undiscounted cash flows expected to result from the use and the eventual disposal of the asset, as well as specific appraisal in certain instances. An impairment loss is recognized when the carrying amount is not recoverable and exceeds fair value.
Foreign currency translation	'
	Foreign currency translation
	The Company’s functional currency and its reporting currency is the United States Dollar.
Cost of Goods Sold	'
	Cost of Goods Sold
	The Company recognizes the direct cost of purchasing product for sale, including freight-in and packaging, as cost of goods sold in the accompanying income statement.
Cash and cash equivalents	'
	Cash and cash equivalents
	The Company includes in cash and cash equivalents all short-term, highly liquid investments that mature within three months of their acquisition date. Cash equivalents consist principally of investments in interest-bearing demand deposit accounts and liquidity funds with financial institutions and are stated at cost, which approximates fair value. For cash management purposes the company concentrates its cash holdings in an account at Bank of America.
Inventory	'
	Inventory
	Inventory consists of finished product, URVape electronic vaporizing cigarettes valued at the lower of cost or market valuation under the first-in, first-out method of costing.
Stock Based Compensation	'
	Stock Based Compensation
	The Companies estimates the fair value of share-based payment awards to employees and directors on the date of grant using an option-pricing model. For stock-based awards issued to employees and directors, stock-based compensation is attributed to expense using the straight-line single option method, which is consistent with how the prior-period pro-forma were provided. Stock-based compensation expense recognized in the Statements of Operations for the years ended March 31, 2013 and 2012 included compensation expense for share-based payment awards granted prior to, but not yet vested based on the grant date fair value estimated and compensation expense for the share-based payment awards granted subsequent to January 1, 2006 based on the grant date fair value estimated.
	The Company’s determination of fair value of share-based payment awards to employees and directors on the date of grant using the Black-Scholes model, which is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to our expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors.
Income Taxes	'
	Income Taxes
	The Company records federal and state income tax liability at the federal and state rates after allowances. Deferred income taxes are provided on the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.
	Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
	Tax benefit from an uncertain tax position may be recognized in the financial statements when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. Income tax positions must meet a more-likely-than-not recognition threshold at the effective date to be recognized and in subsequent periods.
	The Company adopted a policy under which, if required to be recognized in the future, they will classify interest related to the underpayment of income taxes as a component of interest expense and will classify any related penalties in selling, engineering, general and administrating expenses in the statement of operations.
Advertising Costs	'
	Advertising Costs
	Advertising costs are charged to operations as incurred.
Earnings (Loss) Per Share	'
	Earnings (Loss) Per Share
	Basic EPS is calculated by dividing earnings (loss) available to common shareholders by the weighted average number of common shares outstanding during each period.  Diluted EPS is similarly calculated, except that the denominator includes common shares that may be issued subject to existing rights with dilutive potential, except when their inclusion would be anti-dilutive.
	Based on an estimated current value of the Company’s stock being equal to or less than the exercise price of the warrants, none of the shares assumed issued upon conversion of the warrants, nor any of the stock assumed issued under the Company's Incentive Stock Plan are included in the computation of fully diluted loss per share, since their inclusion would be anti-dilutive.
Impact of Recently Issued Accounting Pronouncements	'
	Impact of Recently Issued Accounting Pronouncements
	We have reviewed accounting pronouncements and interpretations thereof that have effectiveness dates during the periods reported and in future periods. We believe that the following impending standards may have an impact on our future filings. The applicability of any standard is subject to the formal review of our financial management and certain standards are under consideration.
	Other recent accounting pronouncements issued by the FASB, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future financial statements.

Property_and_Equipment_Tables

Property and Equipment (Tables)	3 Months Ended
	Jun. 30, 2014
Property, Plant and Equipment [Abstract]	'
Schedule of property and equipment	'
	Property and equipment as of June 30, 2014 and June 30, 2013 consists of the following:
		2014		2013
	Computer equipment	$	-	$	9,873
	Furniture and fixtures		-		17,070
			-		26,943
	Accumulated depreciation		-		24,369
	Net	$	-	$	2,574

Accrued_Expenses_Tables

Accrued Expenses (Tables)	3 Months Ended
	Jun. 30, 2014
Accrued Liabilities, Current [Abstract]	'
Schedule of accrued expenses	'
		2014		2013
	Accrued salaries	$	1,072,714	$	831,527
	Payroll tax liabilities				41,576
	Accrued interest		64,935		0
	Accrued penalties				-
		$	1,137,649	$	873,103

History_of_Company_and_Nature_

History of Company and Nature of Business (Detail Textuals) (USD $)	0 Months Ended
	Jun. 10, 2009	13-May-09
	SeaTech Energy Inc.	Mr. Sam Talari
History Of Company And Nature Of Business [Line Items]	'	'
Principal amount and accrued interest converted into common stock	'	50,000,000
Legally and beneficially owned percentage	'	84.00%
Number of common stock issued in acquisition	150,000,000	'
Amount paid in acquisition	$1,500,000	'

History_of_Company_and_Nature_1

History of Company and Nature of Business (Detail Textuals 1) (USD $)	Jun. 30, 2014	Mar. 31, 2014	8-May-14	Apr. 28, 2014	Jun. 02, 2014	Mar. 19, 2014	Jun. 30, 2014	Jun. 30, 2014	Jun. 30, 2014
			CB Scientific, Inc.	MedTest Inc	URVape, Inc.	HempTech Corp	American Green	American Green	American Green
							Revenue sharing agreement	Revenue sharing agreement	Revenue sharing agreement
								Maximum	Minimum
History Of Company And Nature Of Business [Line Items]	'	'	'	'	'	'	'	'	'
Common stock, shares issued	501,373,966	416,373,966	40,000,000	40,000,000	40,000,000	40,000,000	'	'	'
Common stock, shares outstanding	501,373,966	416,373,966	40,000,000	40,000,000	40,000,000	40,000,000	'	'	'
Present yearly usage for oil (in kilograms)	'	'	'1,000-2,000	'	'	'	'	'	'
Present yearly value for oil	'	'	$200,000,000	'	'	'	'	'	'
Global Nutraceutical market projected to be in excess by 2015	'	'	200,000,000,000	'	'	'	'	'	'
Value of current US Nutraceutical and Dietary supplement market	'	'	42,000,000,000	'	'	'	'	'	'
Monthly leasing fee	'	'	'	'	'	'	$150	'	'
Transation Cost Per Machine	'	'	'	'	'	'	'	2	1.5

Basis_of_Presentation_Business2

Basis of Presentation, Business and Summary of Significant Accounting Policies (Detail Textuals)	3 Months Ended
	Jun. 30, 2014
Accounting Policies [Abstract]	'
Depreciation method for Property and Equipment	'straight-line method
Estimated useful lives for Property and Equipment	'three to seven years
Software Development Costs estimated economic life	'10 years

Going_Concern_Detail_Textuals

Going Concern (Detail Textuals) (USD $)	3 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Mar. 31, 2014
Liquidity Disclosure [Abstract]	'	'	'
Net loss	$178,871	$54,169	'
Cumulative net loss	6,242,293	'	6,063,422
Working capital	133,437	'	'
Cash	$133,437	'	'

Property_and_Equipment_Summary

Property and Equipment - Summary of property and equipment (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
Property, Plant and Equipment [Line Items]	'	'
Property and equipment Gross	'	$26,943
Accumulated depreciation	'	24,369
Total Property and Equipment, Net of Depreciation	'	2,574
Computer equipment	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment Gross	'	9,873
Furniture and fixtures	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment Gross	'	$17,070

Stock_Issuances_Detail_Textual

Stock Issuances (Detail Textuals) (MedTest Inc, Common Stock, USD $)	3 Months Ended
	Jun. 30, 2014
MedTest Inc | Common Stock	'
Stock Issuances [Line Items]	'
Restricted Common stock issued for the purchase	$5,000,000

Accrued_Expenses_Summary_of_ac

Accrued Expenses - Summary of accrued expenses (Details) (USD $)	Jun. 30, 2014	Mar. 31, 2014	Jun. 30, 2013
Accrued Liabilities, Current [Abstract]	'	'	'
Accrued salaries	$1,072,714	'	$831,527
Payroll tax liabilities	'	'	41,576
Accrued interest	64,935	'	0
Accrued expenses Total	$1,137,341	$1,089,530	$873,103

Related_Parties_Disclosures_De

Related Parties Disclosures (Detail Textuals) (Saeed (Sam) Talari, USD $)	Jun. 30, 2014	Mar. 31, 2014	Jun. 30, 2013	Apr. 01, 2010
Saeed (Sam) Talari	'	'	'	'
Related Party Transaction [Line Items]	'	'	'	'
Initial balance of promissory note	'	'	'	$306,319
Interest bearing percentage	'	'	'	5.00%
Balance due to related party	223,844	'	299,118	'
Accrued interest	$64,935	$45,048	'	'

Employment_Agreements_Detail_T

Employment Agreements (Detail Textuals) (USD $)

Jun. 30, 2014

Jun. 30, 2013

Jan. 01, 2012

Jun. 30, 2014

Mar. 31, 2014

Apr. 15, 2014

Apr. 24, 2014

Apr. 21, 2014

15-May-14

15-May-14

Jun. 18, 2014

Jun. 18, 2014

Mr. Sam Talari

Mr. Sam Talari

Mr. Sam Talari

Mr. Cameron Cox

Mr. Bill Short

Mr. Kevin Defant

Mr. Derek Lebahn

Mr. Charles Steinberg

Mr. Joseph Kelly

Mr. Scott Zabrek

Employment Agreement

Employment Agreement

Employment Agreement

Employment Agreement

Employment Agreement

Employment Agreement

Employment Agreement

Employment Agreement

Employment Agreement

Employment Agreement

Employment Agreements [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Term of agreement

'

'

'3 years

'

'

'3 years

'3 years

'3 years

'3 years

'3 years

'3 years

'3 years

Extended term of agreement

'

'

'1 year

'

'

'1 year

'1 year

'1 year

'1 year

'1 year

'1 year

'1 year

Termination of agreement notice period description

'

'

'within 90 days of the end of any periods

'

'

'within 90 days of the end of any periods

'within 90 days of the end of any periods

'within 90 days of the end of any periods

'within 90 days of the end of any periods

'within 90 days of the end of any periods

'within 90 days of the end of any periods

'within 90 days of the end of any periods

Base salary per month

'

'

$9,371

'

'

$3,000

$3,000

$2,000

$2,000

$2,000

$850

$2,000

Percentage of increase in salary per annum

'

'

5.00%

'

'

5.00%

5.00%

5.00%

5.00%

5.00%

5.00%

5.00%

Accrued salaries payable

$1,072,714

$831,527

'

$1,037,284

$900,733

'

'

'

'

'

'

'